402 related articles for article (PubMed ID: 34938289)
21. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
Front Immunol; 2021; 12():798338. PubMed ID: 35095877
[TBL] [Abstract][Full Text] [Related]
22. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
[TBL] [Abstract][Full Text] [Related]
23. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
24. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
25. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
26. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.
Krysko O; Kondakova E; Vershinina O; Galova E; Blagonravova A; Gorshkova E; Bachert C; Ivanchenko M; Krysko DV; Vedunova M
Front Immunol; 2021; 12():715072. PubMed ID: 34539644
[TBL] [Abstract][Full Text] [Related]
27. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
28. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
29. Cytokine profile and disease severity in patients with COVID-19.
Ghazavi A; Ganji A; Keshavarzian N; Rabiemajd S; Mosayebi G
Cytokine; 2021 Jan; 137():155323. PubMed ID: 33045526
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
[TBL] [Abstract][Full Text] [Related]
31. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
32. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
Petrey AC; Qeadan F; Middleton EA; Pinchuk IV; Campbell RA; Beswick EJ
J Leukoc Biol; 2021 Jan; 109(1):55-66. PubMed ID: 32930456
[TBL] [Abstract][Full Text] [Related]
33. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
Front Immunol; 2021; 12():626235. PubMed ID: 33584733
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
PeerJ; 2024; 12():e17257. PubMed ID: 38646483
[TBL] [Abstract][Full Text] [Related]
35. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.
Petruccioli E; Najafi Fard S; Navarra A; Petrone L; Vanini V; Cuzzi G; Gualano G; Pierelli L; Bertoletti A; Nicastri E; Palmieri F; Ippolito G; Goletti D
J Transl Med; 2021 Jun; 19(1):272. PubMed ID: 34174875
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Quartuccio L; Fabris M; Sonaglia A; Peghin M; Domenis R; Cifù A; Curcio F; Tascini C
Cytokine; 2021 Apr; 140():155438. PubMed ID: 33493861
[TBL] [Abstract][Full Text] [Related]
37. Cytokine Signature Associated With Disease Severity in COVID-19.
Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
Front Immunol; 2021; 12():681516. PubMed ID: 34489933
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
39. An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Abers MS; Delmonte OM; Ricotta EE; Fintzi J; Fink DL; de Jesus AAA; Zarember KA; Alehashemi S; Oikonomou V; Desai JV; Canna SW; Shakoory B; Dobbs K; Imberti L; Sottini A; Quiros-Roldan E; Castelli F; Rossi C; Brugnoni D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Castagnoli R; Montagna D; Licari A; Marseglia GL; Gliniewicz EF; Shaw E; Kahle DE; Rastegar AT; Stack M; Myint-Hpu K; Levinson SL; DiNubile MJ; Chertow DW; Burbelo PD; Cohen JI; Calvo KR; Tsang JS; ; Su HC; Gallin JI; Kuhns DB; Goldbach-Mansky R; Lionakis MS; Notarangelo LD
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232303
[TBL] [Abstract][Full Text] [Related]
40. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
